Paper36860655
Landscape of Genetic Alterations Underlying Hallmark Signature Changes in Cancer Reveals TP53 Aneuploidy-driven Metabolic Reprogramming.
McClure MB and 11 others. Cancer Res Commun, 2023. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Landscape of Genetic Alterations Underlying Hallmark Signature Changes in Cancer Reveals TP53 Aneuploidy-driven Metabolic Reprogramming. Papers, record 36860655. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36860655
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Carcinoma, Squamous Cell | Major topic |
| Humans | |
| Mice | |
| Animals | |
| Female | |
| Tumor Suppressor Protein p53 | |
| Mutation | |
| Aneuploidy |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 ES010126 | NIEHS NIH HHS | United States | P30ES010126 | PubMed | NIH RePORTER |
| R01 CA148761 | NCI NIH HHS | United States | R01CA148761 | PubMed and NIH | NIH RePORTER |
| P50 CA058223 | NCI NIH HHS | United States | P50CA058223 | PubMed | NIH RePORTER |
| P20 CA233307 | NCI NIH HHS | United States | P20CA233307 | PubMed and NIH | NIH RePORTER |
| R01 MD013452 | NIMHD NIH HHS | United States | R01MD013452 | PubMed and NIH | NIH RePORTER |
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31068700 | Next-generation characterization of the Cancer Cell Line Encyclopedia. | Nature | 2019 | https://conductscience.org/library/papers/31068700 | PubMed |
| 2 | 29448085 | Plk2 Loss Commonly Occurs in Colorectal Carcinomas but not Adenomas: Relationship to mTOR Signaling. | Neoplasia | 2018 | https://conductscience.org/library/papers/29448085 | PubMed |
| 3 | 23539594 | Cancer genome landscapes. | Science | 2013 | https://conductscience.org/library/papers/23539594 | PubMed |
| 4 | 28622513 | Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. | Cell | 2017 | https://conductscience.org/library/papers/28622513 | PubMed |
| 5 | 27634447 | Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? | Nat Rev Cancer | 2016 | https://conductscience.org/library/papers/27634447 | PubMed |
| 6 | 28988769 | Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. | Cell | 2017 | https://conductscience.org/library/papers/28988769 | PubMed |
| 7 | 28162975 | Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. | Cancer Cell | 2017 | https://conductscience.org/library/papers/28162975 | PubMed |
| 8 | 30635634 | TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups. | Leukemia | 2019 | https://conductscience.org/library/papers/30635634 | PubMed |
| 9 | 29625048 | Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer. | Cell | 2018 | https://conductscience.org/library/papers/29625048 | PubMed |
| 10 | 22522925 | The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. | Nature | 2012 | https://conductscience.org/library/papers/22522925 | PubMed |
| 11 | 35156101 | Tumor suppressor PLK2 may serve as a biomarker in triple-negative breast cancer for improved response to PLK1 therapeutics. | Cancer Res Commun | 2021 | https://conductscience.org/library/papers/35156101 | PubMed |
| 12 | 25109877 | Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. | Cell | 2014 | https://conductscience.org/library/papers/25109877 | PubMed |
| 13 | 27653561 | Toward a Shared Vision for Cancer Genomic Data. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27653561 | PubMed |
| 14 | 28187443 | Analysis of The Cancer Genome Atlas sequencing data reveals novel properties of the human papillomavirus 16 genome in head and neck squamous cell carcinoma. | Oncotarget | 2017 | https://conductscience.org/library/papers/28187443 | PubMed |
| 15 | 31068703 | The landscape of cancer cell line metabolism. | Nat Med | 2019 | https://conductscience.org/library/papers/31068703 | PubMed |
| 16 | 26536169 | Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. | N Engl J Med | 2016 | https://conductscience.org/library/papers/26536169 | PubMed |
| 17 | 21527027 | GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. | Genome Biol | 2011 | https://conductscience.org/library/papers/21527027 | PubMed |
| 18 | 29625053 | Comprehensive Characterization of Cancer Driver Genes and Mutations. | Cell | 2018 | https://conductscience.org/library/papers/29625053 | PubMed |
| 19 | 29622463 | Genomic and Functional Approaches to Understanding Cancer Aneuploidy. | Cancer Cell | 2018 | https://conductscience.org/library/papers/29622463 | PubMed |
| 20 | 12829800 | Repeated observation of breast tumor subtypes in independent gene expression data sets. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12829800 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42225967 | TP53 deficiency in AML induces resistance to T-cell engagers through an immunosuppressive secretome. | Leukemia | 2026 | https://conductscience.org/library/papers/42225967 | PubMed |
| 41674841 | Concurrent Germline-Somatic Alterations and Associations with Cancer Outcomes: A Systematic Review of Concurrent Data Use. | Res Sq | 2026 | https://conductscience.org/library/papers/41674841 | PubMed |
| 41133008 | TTF-1 and p40 co-expression defines a distinct subtype of non-small cell lung cancer with frequent TP53 mutations and FGFR pathway dysregulation. | Transl Lung Cancer Res | 2025 | https://conductscience.org/library/papers/41133008 | PubMed |
| 40565062 | Metabolic Reprogramming of Urothelial Carcinoma-A Theragnostic Target for Betulinic Acid. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40565062 | PubMed |
| 40333415 | The Hallmarks of Aneuploidy in Cancer and Congenital Syndromes. | Annu Rev Genomics Hum Genet | 2025 | https://conductscience.org/library/papers/40333415 | PubMed |
| 39885167 | Understanding metastasis mixed-treatment responses through genomic analyses. | NPJ Breast Cancer | 2025 | https://conductscience.org/library/papers/39885167 | PubMed |
| 39725169 | Interferon Epsilon Loss Is Elusive 9p21 Link to Immune-Cold Tumors, Resistant to Immune Checkpoint Therapy, and Endogenous CXCL9/10 Induction. | J Thorac Oncol | 2025 | https://conductscience.org/library/papers/39725169 | PubMed |
| 39493875 | PhosCancer: A comprehensive database for investigating protein phosphorylation in human cancer. | iScience | 2024 | https://conductscience.org/library/papers/39493875 | PubMed |
| 39405607 | Role of glucose metabolic reprogramming in colorectal cancer progression and drug resistance. | Transl Oncol | 2024 | https://conductscience.org/library/papers/39405607 | PubMed |
| 39161899 | Impact of p53-associated acute myeloid leukemia hallmarks on metabolism and the immune environment. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39161899 | PubMed |
| 38924459 | Patterns of Aneuploidy and Signaling Consequences in Cancer. | Cancer Res | 2024 | https://conductscience.org/library/papers/38924459 | PubMed |
| 38688924 | Molecular profiling of a bladder cancer with very high tumour mutational burden. | Cell Death Discov | 2024 | https://conductscience.org/library/papers/38688924 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36860655
GET https://conductscience.org/api/papers/v1/36860655/references?page=2